The market for ready-to-use (RTU) syringes is growing rapidly. In fact, experts anticipate an annual growth rate of about eight percent over the next ten years. In response to this demand, Syntegon has expanded its inspection portfolio with the new AIM DIRect to include integrated de-nesting and re…

– RMA assembly solution for pens and autoinjectors recognized for user-friendliness and seamless processes.
– Design simplifies operations and enables flexible production.
– Long-term value for pharmaceutical manufacturers of, for example, antidiabetics and weight-control products.

Syntegon has received t…

– Eros Carletti joined Syntegon as new CFO effective January 6, 2025
– Peter Hackel resigned on December 31, 2024, after two successful years

The Syntegon Group, a strategic partner to the global pharmaceutical and food industries, has appointed Eros Carletti as new Chief Financial Officer (CFO). He joi…

– State-of-the-art facility built to boost collaboration
– Designed with the customer in mind
– Construction project completed ahead of schedule after 18 months

The leading provider of processing and packaging solutions Syntegon has completed the construction of its new office building at its Crailsheim p…

– Sustainability confirmed as key element of Syntegon’s corporate strategy
– Syntegon aims to reduce Scope 3 CO2 emissions by 25 percent, as well as Scope 1 and 2 emissions by 48.3 percent until 2030
– Lifecycle approach along the value chain: from seamless processes and innovative technologies to sust…

– Strengthening strategic growth with a seamless technology and service portfolio
– Significantly expanded pharmaceutical liquid filling offering
– Very positive customer feedback and first inquiries for joint projects

Following regulatory approval, Syntegon and Azbil Corporation have officially closed th…

Most OSD drug manufacturing companies may know the TPR tablet compression range from Syntegon. It has been part of the portfolio for exactly ten years now and is installed in many facilities around the globe. However, its history goes back a lot longer – and takes us to the origins of Manesty tabl…

In light of the new version of Annex 1, which came into force in August 2023, many pharmaceutical manufacturers are facing the question whether they must invest in new equipment. However, in many cases upgrades are a good alternative, as the Danish company AJ Vaccines showed. Together with this cust…

Air handling in isolators takes up a considerable amount of space with boxy units and great lengths of piping. "In-air" isolators from Syntegon eliminate the need for traditional air handling solutions by integrating the technology into the plenum of the isolator.

Air handling technology plays an imp…

– Syntegon launches patented new development for the pharmaceutical industry
– Focus on Annex 1 compliance: reducing machine stops, manual intervention, and contamination risks in the aseptic filling process
– Seamless and sustainable integration into new and existing equipment

There was a lot to see at t…